From Molecular Therapies to Lysosomal Transplantation and Targeted Drug Strategies: Present Applications, Limitations, and Future Prospects of Lysosomal Medications
Lysosomes are essential intracellular organelles involved in plentiful cellular processes such as cell signaling, metabolism, growth, apoptosis, autophagy, protein processing, and maintaining cellular homeostasis. Their dysfunction is linked to various diseases, including lysosomal storage disorders...
Saved in:
| Main Authors: | Adel A. Alhowyan, Gamaleldin I. Harisa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/3/327 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases?
by: Federico Spataro, et al.
Published: (2025-06-01) -
The rapidly evolving view of lysosomal storage diseases
by: Giancarlo Parenti, et al.
Published: (2021-01-01) -
Impairment of chaperone‐mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis
by: Gennaro Napolitano, et al.
Published: (2015-01-01) -
Lysosomal dysfunction disrupts presynaptic maintenance and restoration of presynaptic function prevents neurodegeneration in lysosomal storage diseases
by: Irene Sambri, et al.
Published: (2016-11-01) -
Clinical guidelines for the management of children with lysosomal acid lipase deficiency
by: Inga V. Anisimova, et al.
Published: (2023-08-01)